Feasibility Study of an Interactive Wall-Based Intervention Program for Nursing Home Residents and Patients in Long-Term Care Facilities: Mur'Aventure (MUR'AVENTURE)
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Elodie Piche, PhD
- 电话号码:+33492034925
- 邮箱:piche.e@chu-nice.fr
研究联系人备份
- 姓名:Assia Bebiche Lamali, MD
- 电话号码:+33492034925
- 邮箱:bebiche-lamali.a@chu-nice.fr
学习地点
-
-
-
Nice、法国
- Chu De Nice
-
接触:
- Elodie Piche, PhD
- 电话号码:+33492034925
- 邮箱:piche.e@chu-nice.fr
-
首席研究员:
- Assia Bebiche Lamali, MD
-
-
参与标准
资格标准
适合学习的年龄
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Adults aged 65 years or older.
- Resident of a nursing home (EHPAD) or long-term care unit (USLD).
- Affiliated with the French national health insurance system.
- Able to participate in low-to-moderate intensity adapted physical activity.
- No cognitive impairment or mild-to-moderate cognitive impairment compatible with understanding simple instructions (MoCA >18 and physician approval).
- Written informed consent provided by the participant or legal representative.
Exclusion Criteria:
- Medical contraindication to adapted physical activity.
- Severe neurological or psychiatric disorder incompatible with safe participation.
- Severe uncorrected visual, auditory or sensory impairment preventing interaction with the immersive wall.
- Inability to understand instructions despite adaptation.
- Participation in another interventional study that may interfere with study outcomes.
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Immersive Interactive Wall Exergame Program (Mur'Aventure)
|
Participants will complete a supervised 12-week adapted physical activity program delivered through an immersive interactive wall (NeoXperience).
Sessions will be performed twice weekly in groups of four participants and will last approximately 40 minutes, including a warm-up.
Games are adapted to participants' physical and cognitive abilities and combine cognitive stimulation with whole-body movements.
Heart rate, physical activity intensity, game performance, perceived exertion, fatigue and enjoyment will be monitored throughout the intervention.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Acceptability of the Mur'Aventure program assessed using the French System Usability Scale (F-SUS)
大体时间:During the 12-week intervention and immediately after the intervention.
|
Acceptability will be assessed using the French version of the System Usability Scale (F-SUS), a validated 10-item questionnaire evaluating the perceived usability of a system. Total scores range from 0 to 100, with higher scores indicating greater usability and acceptability. Acceptability will be considered achieved if at least 70% of participants obtain a score >70. Feasibility will be considered successful if all three predefined feasibility criteria (acceptability, adherence, and safety) are met. If one or more criteria are not met, the feasibility of the intervention will be interpreted in light of the unmet criterion(ia), and potential modifications to the intervention or study procedures will be discussed. |
During the 12-week intervention and immediately after the intervention.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Program adherence : predefined feasibility criteria
大体时间:Throughout the 12-week intervention.
|
Adherence will be evaluated by the completion rate, defined as the proportion of participants completing the entire 12-week intervention.
Adherence will be considered good if the completion rate is ≥70%.
Attendance rate and dropout rate will also be reported descriptively.
|
Throughout the 12-week intervention.
|
|
Safety of the Mur'Aventure program : predefined feasibility criteria
大体时间:Throughout the 12-week intervention
|
Safety will be assessed by recording the occurrence of serious adverse events (SAEs) throughout the intervention.
Safety will be considered acceptable if no serious adverse events related to the intervention occur.
Additional descriptive safety measures include perceived fatigue, perceived exertion, and heart rate responses recorded during each intervention session.
|
Throughout the 12-week intervention
|
|
Intervention fidelity
大体时间:Throughout the 12-week intervention
|
To describe the fidelity of program implementation, assessed by the proportion of intervention sessions delivered according to the planned protocol Intervention fidelity will be assessed as the percentage of planned exercise sessions completed according to the study protocol.
Higher percentages indicate greater fidelity to the intervention.
|
Throughout the 12-week intervention
|
|
Change in Montreal Cognitive Assessment (MoCA) total score
大体时间:Baseline and immediately after the 12-week intervention
|
To explore the preliminary effects of the program on cognitive function, assessed by the change in the Montreal Cognitive Assessment (MoCA) total score Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a validated 30-point cognitive screening instrument evaluating memory, executive function, attention, language, visuospatial abilities, abstraction, and orientation.
Scores range from 0 to 30, with higher scores indicating better cognitive function.
The outcome is the change in total score between baseline and the end of the intervention.
|
Baseline and immediately after the 12-week intervention
|
|
Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L) score
大体时间:Baseline and immediately after the 12-week intervention
|
To explore the preliminary effects of the program on health-related quality of life, assessed by the change in the EuroQol 5-Dimension 5-Level (EQ-5D-5L) score from baseline to post-intervention. Health-related quality of life will be assessed using the EQ-5D-5L questionnaire, which evaluates mobility, self-care, usual activities, pain/discomfort, and anxiety/depression across five severity levels. Responses are converted into an EQ-5D index value, with higher index values indicating better health-related quality of life. The change in EQ-5D index score between baseline and the end of the intervention will be analyzed |
Baseline and immediately after the 12-week intervention
|
|
Change in Mini-Geriatric Depression Scale (Mini-GDS) score
大体时间:Baseline and immediately after the 12-week intervention.
|
To explore the preliminary effects of the program on self-reported psychological well-being, assessed by the change in the 4-item Mini-Geriatric Depression Scale (Mini-GDS) score from baseline to post-intervention. Psychological well-being will be assessed using the 4-item Mini-Geriatric Depression Scale (Mini-GDS). Scores range from 0 to 4, with higher scores indicating more depressive symptoms and poorer psychological well-being. The outcome is the change in total score between baseline and the end of the intervention |
Baseline and immediately after the 12-week intervention.
|
|
Change in QUALIDEM total score
大体时间:Baseline and immediately after the 12-week intervention.
|
To explore the preliminary effects of the program on caregiver-observed well-being, assessed by the change in the French version of the QUALIDEM total score from baseline to post-intervention. Observed well-being will be assessed using the French version of the QUALIDEM questionnaire, a proxy-rated instrument evaluating quality of life in older adults with cognitive impairment. Higher score indicating better quality of life. The outcome is the change in total score between baseline and the end of the intervention. |
Baseline and immediately after the 12-week intervention.
|
|
Mean heart rate during intervention sessions
大体时间:During each intervention session throughout the 12-week intervention.
|
To describe the physical stimulation induced by the intervention sessions, assessed using heart rate and measured during each session with the Polar Unite wearable device Heart rate will be continuously recorded during each exercise session using a Polar Unite heart rate monitor.
Mean heart rate (beats per minute) as well as maximal heart rate will be calculated for each participant during each session.
Higher values indicate greater cardiovascular response to exercise.
|
During each intervention session throughout the 12-week intervention.
|
|
Cognitive stimulation during the intervention
大体时间:During each intervention session throughout the 12-week intervention
|
To describe cognitive stimulation during the intervention, assessed using the game score, number of errors, and completion time automatically recorded during each session Cognitive stimulation will be assessed using the total score, number of errors and completion time automatically recorded by the Mur'Aventure interactive wall software during each exercise session.
Higher scores indicate better cognitive stimulation.
|
During each intervention session throughout the 12-week intervention
|
|
Mean physical load during intervention sessions
大体时间:During each intervention session throughout the 12-week intervention.
|
To describe the physical stimulation induced by the intervention sessions, assessed using heart rate and physical load measured during each session with the Polar Unite wearable device Physical load will be estimated using the Polar Unite wearable device.
The device provides a proprietary estimate of exercise load based on heart rate and movement data recorded during each session.
Higher values indicate greater physical exercise load.
|
During each intervention session throughout the 12-week intervention.
|
|
Game engagement during the intervention
大体时间:During each intervention session throughout the 12-week intervention
|
To describe game engagement during the intervention, assessed using the game score, number of errors, and completion time automatically recorded during each session Game engagement will be assessed using the total score, number of errors and completion time automatically recorded by the Mur'Aventure interactive wall software during each exercise session.
Higher scores indicate better game performance.
|
During each intervention session throughout the 12-week intervention
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- [25-AOIP-06
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.